Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Outcomes of initial hemodialysis vascular access in patients initiating dialysis with a tunneled catheter.

Copeland T, Lawrence P, Woo K.

J Vasc Surg. 2019 May 27. pii: S0741-5214(19)30374-X. doi: 10.1016/j.jvs.2019.02.036. [Epub ahead of print]

PMID:
31147122
2.

Randomized Trial Based on the Common-Sense Model of Self-regulation to Increase Child Dental Visits.

Nelson S, Milgrom P, Albert JM, Selvaraj D, Cunha-Cruz J, Curtan S, Copeland T, Heima M, Rothen M, Beck G, Ferretti G, Riedy C.

JDR Clin Trans Res. 2019 Feb 22:2380084419830662. doi: 10.1177/2380084419830662. [Epub ahead of print]

PMID:
30931720
3.

Palliative care and imaging utilisation for patients with cancer.

Raghavan K, Copeland TP, Rabow M, Ladenheim M, Marks A, Pantilat SZ, O'Riordan D, Seidenwurm D, Franc B.

BMJ Support Palliat Care. 2019 Mar 1. pii: bmjspcare-2018-001572. doi: 10.1136/bmjspcare-2018-001572. [Epub ahead of print]

PMID:
30826736
4.

Strength is in numbers when participating in an Accountable Care Organization.

Smith TA, Kresowik T, Woo K, Copeland TP.

J Vasc Surg. 2019 Mar;69(3):965. doi: 10.1016/j.jvs.2018.12.018. No abstract available.

PMID:
30798847
5.

Differences in V[Combining Dot Above]O2peak of Surfers When Paddling in Water vs. on a Swimbench Ergometer.

Furr HN, Warner ME, Copeland TL, Robles-Rodríguez C, Ponce-González JG, Nessler JA, Newcomer SC.

J Strength Cond Res. 2019 Apr;33(4):1095-1101. doi: 10.1519/JSC.0000000000003072.

PMID:
30707140
6.

Scoring bonuses in the Merit-based Incentive Payment System.

Ho SY, Woo K, Copeland TP.

J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):145. doi: 10.1016/j.jvsv.2018.09.001. No abstract available.

PMID:
30554743
7.

Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, D'Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE; VITAL Research Group.

N Engl J Med. 2019 Jan 3;380(1):23-32. doi: 10.1056/NEJMoa1811403. Epub 2018 Nov 10.

PMID:
30415637
8.

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D'Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE; VITAL Research Group.

N Engl J Med. 2019 Jan 3;380(1):33-44. doi: 10.1056/NEJMoa1809944. Epub 2018 Nov 10.

PMID:
30415629
9.

A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain.

Ding Y, Sohn JH, Kawczynski MG, Trivedi H, Harnish R, Jenkins NW, Lituiev D, Copeland TP, Aboian MS, Mari Aparici C, Behr SC, Flavell RR, Huang SY, Zalocusky KA, Nardo L, Seo Y, Hawkins RA, Hernandez Pampaloni M, Hadley D, Franc BL.

Radiology. 2019 Feb;290(2):456-464. doi: 10.1148/radiol.2018180958. Epub 2018 Nov 6.

PMID:
30398430
10.

Meaningful incentive payment system scoring.

Woo K, Rathbun JA, Copeland TP.

J Vasc Surg Venous Lymphat Disord. 2018 Nov;6(6):801. doi: 10.1016/j.jvsv.2018.09.009. No abstract available.

PMID:
30336909
11.

Quality measures in the Merit-based Incentive Payment System.

Simons JP, Woo K, Rathbun JA, Johnson BL, Copeland TP.

J Vasc Surg. 2018 Sep;68(3):931-932. doi: 10.1016/j.jvs.2018.06.102. No abstract available.

PMID:
30144914
12.

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis.

Huang SY, Franc BL, Harnish RJ, Liu G, Mitra D, Copeland TP, Arasu VA, Kornak J, Jones EF, Behr SC, Hylton NM, Price ER, Esserman L, Seo Y.

NPJ Breast Cancer. 2018 Aug 16;4:24. doi: 10.1038/s41523-018-0078-2. eCollection 2018.

13.

VITamin D and OmegA-3 TriaL (VITAL) bone health ancillary study: clinical factors associated with trabecular bone score in women and men.

Goldman AL, Donlon CM, Cook NR, Manson JE, Buring JE, Copeland T, Yu CY, LeBoff MS.

Osteoporos Int. 2018 Nov;29(11):2505-2515. doi: 10.1007/s00198-018-4633-3. Epub 2018 Jul 18.

PMID:
30022253
14.

Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer.

Franc BL, Copeland TP, Thombley R, Park M, Marafino B, Dean ML, Boscardin WJ, Rugo HS, Seidenwurm D, Sharma B, Johnston SR, Dudley RA.

J Natl Compr Canc Netw. 2018 Jul;16(7):829-837. doi: 10.6004/jnccn.2018.7024.

PMID:
30006425
15.

Dorsal and ventral hippocampal adult-born neurons contribute to context fear memory.

Huckleberry KA, Shue F, Copeland T, Chitwood RA, Yin W, Drew MR.

Neuropsychopharmacology. 2018 Nov;43(12):2487-2496. doi: 10.1038/s41386-018-0109-6. Epub 2018 Jun 2.

PMID:
29941977
16.

Another means to meet MIPs requirements: The virtual group.

Knepper J, Woo K, Rathbun J, Johnson B, Copeland TP.

J Vasc Surg. 2018 Aug;68(2):650. doi: 10.1016/j.jvs.2018.06.018. Epub 2018 Jun 21. No abstract available.

PMID:
29937286
17.

Use and impact of patient relationship modifiers on cost measurement.

Larson RA, Johnson B, Woo K, Rathbun JA, Copeland TP.

J Vasc Surg. 2018 Jul;68(1):307. doi: 10.1016/j.jvs.2018.05.030. No abstract available.

PMID:
29937035
18.

Cost measurement in the meaningful incentive payment system.

Copeland TP, Woo K.

J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):551. doi: 10.1016/j.jvsv.2018.04.002. No abstract available.

PMID:
29909862
19.

Acute Suppurative Thyroiditis in an Intravenous Drug User with a Preexisting Goiter.

Yegya-Raman N, Copeland T, Parikh P.

Case Rep Med. 2018 Mar 26;2018:5098712. doi: 10.1155/2018/5098712. eCollection 2018.

20.

The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.

Okereke OI, Reynolds CF 3rd, Mischoulon D, Chang G, Cook NR, Copeland T, Friedenberg G, Buring JE, Manson JE.

Contemp Clin Trials. 2018 May;68:133-145. doi: 10.1016/j.cct.2018.02.017. Epub 2018 Mar 8.

21.

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test.

Laman-Maharg A, Williams AV, Zufelt MD, Minie VA, Ramos-Maciel S, Hao R, Ordoñes Sanchez E, Copeland T, Silverman JL, Leigh A, Snyder R, Carroll FI, Fennell TR, Trainor BC.

Front Pharmacol. 2018 Feb 14;9:93. doi: 10.3389/fphar.2018.00093. eCollection 2018.

22.

Quality Payment Program year 2.

Rathbun J, Johnson B, Woo K, Copeland TP.

J Vasc Surg. 2018 Mar;67(3):984. doi: 10.1016/j.jvs.2017.12.015. No abstract available.

PMID:
29477207
23.

Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture.

Donlon CM, LeBoff MS, Chou SH, Cook NR, Copeland T, Buring JE, Bubes V, Kotler G, Manson JE.

Contemp Clin Trials. 2018 Apr;67:56-67. doi: 10.1016/j.cct.2018.02.003. Epub 2018 Feb 23.

24.

To Keep this Disease from Killing You: Cultural Competence, Consonance, and Health among HIV-positive Women in Kenya.

Copeland T.

Med Anthropol Q. 2018 Jun;32(2):272-292. doi: 10.1111/maq.12402. Epub 2017 Dec 11.

PMID:
28766753
25.

Contextualizing Oncologic Imaging Utilization Through End-of-Life Spending Patterns.

Copeland TP, Hillman JM, Franc BL.

J Am Coll Radiol. 2017 Oct;14(10):1269-1278. doi: 10.1016/j.jacr.2017.06.004. Epub 2017 Jul 12.

PMID:
28709782
26.

The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.

Laman-Maharg AR, Copeland T, Sanchez EO, Campi KL, Trainor BC.

Behav Brain Res. 2017 Aug 14;332:299-307. doi: 10.1016/j.bbr.2017.06.015. Epub 2017 Jun 15.

27.

Self-managing HIV/AIDS: cultural competence and health among women in Nairobi, Kenya.

Copeland T.

Anthropol Med. 2018 Aug;25(2):176-190. doi: 10.1080/13648470.2017.1285002. Epub 2017 May 11.

PMID:
28492085
28.

Contextualizing the use of oncologic imaging within treatment phases: imaging trends and modality preferences, 2000-2014.

Copeland TP, Creasman JM, Seidenwurm DJ, Franc BL.

Curr Oncol. 2017 Apr;24(2):e99-e105. doi: 10.3747/co.24.3216. Epub 2017 Apr 27.

29.

Implementation and Evaluation of the Safety Net Specialty Care Program in the Denver Metropolitan Area.

Fort MP, Namba LM, Dutcher S, Copeland T, Bermingham N, Fellenz C, Lantz D, Reusch JJ, Bayliss EA.

Perm J. 2017;21:16-022. doi: 10.7812/TPP/16-022.

30.

Setting spatial conservation priorities despite incomplete data for characterizing metapopulations.

Fullerton AH, Anzalone S, Moran P, Van Doornik DM, Copeland T, Zabel RW.

Ecol Appl. 2016 Dec;26(8):2558-2578. doi: 10.1002/eap.1411. Epub 2016 Nov 16.

PMID:
27865061
31.

Biomechanical Modeling of the Forces Applied to Closed Incisions During Single-Use Negative Pressure Wound Therapy.

Loveluck J, Copeland T, Hill J, Hunt A, Martin R.

Eplasty. 2016 Jul 13;16:e20. eCollection 2016.

32.

Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.

Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, Muravov O, Horton K.

MMWR Surveill Summ. 2016 Aug 5;65(8):1-12. doi: 10.15585/mmwr.ss6508a1.

PMID:
27490513
33.

Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.

Gold DR, Litonjua AA, Carey VJ, Manson JE, Buring JE, Lee IM, Gordon D, Walter J, Friedenberg G, Hankinson JL, Copeland T, Luttmann-Gibson H.

Contemp Clin Trials. 2016 Mar;47:185-95. doi: 10.1016/j.cct.2016.01.003. Epub 2016 Jan 16.

34.

Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).

Bassuk SS, Manson JE, Lee IM, Cook NR, Christen WG, Bubes VY, Gordon DS, Copeland T, Friedenberg G, D'Agostino DM, Ridge CY, MacFadyen JG, Kalan K, Buring JE.

Contemp Clin Trials. 2016 Mar;47:235-43. doi: 10.1016/j.cct.2015.12.022. Epub 2016 Jan 6.

35.
36.

Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.

Sacks FM, Carey VJ, Anderson CA, Miller ER 3rd, Copeland T, Charleston J, Harshfield BJ, Laranjo N, McCarron P, Swain J, White K, Yee K, Appel LJ.

JAMA. 2014 Dec 17;312(23):2531-41. doi: 10.1001/jama.2014.16658.

37.

Spatial variation buffers temporal fluctuations in early juvenile survival for an endangered Pacific salmon.

Thorson JT, Scheuerell MD, Buhle ER, Copeland T.

J Anim Ecol. 2014 Jan;83(1):157-67. doi: 10.1111/1365-2656.12117. Epub 2013 Aug 6.

PMID:
23919254
38.

RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa.

Westhoff CM, Vege S, Halter Hipsky C, Hue-Roye K, Copeland T, Velliquette RW, Horn T, Lomas-Francis C, Reid ME.

Transfusion. 2013 Apr;53(4):741-6. doi: 10.1111/j.1537-2995.2012.03800.x. Epub 2012 Jul 13.

39.

Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.

Kerger BD, Copeland TL, DeCaprio AP.

Drug Chem Toxicol. 2011 Oct;34(4):396-404. doi: 10.3109/01480545.2011.582502. Epub 2011 Jul 19. Review.

PMID:
21770727
40.

The effects of feeding history and environment on condition, body composition and growth of bluegills Lepomis macrochirus.

Copeland T, Murphy BR, Ney JJ.

J Fish Biol. 2010 Feb;76(3):538-55. doi: 10.1111/j.1095-8649.2009.02507.x.

PMID:
20666895
41.

RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity.

Lee S, Shuman JD, Guszczynski T, Sakchaisri K, Sebastian T, Copeland TD, Miller M, Cohen MS, Taunton J, Smart RC, Xiao Z, Yu LR, Veenstra TD, Johnson PF.

Mol Cell Biol. 2010 Jun;30(11):2621-35. doi: 10.1128/MCB.00782-09. Epub 2010 Mar 29.

42.

Implementing a low-fat eating plan in the Women's Intervention Nutrition Study.

Hoy MK, Winters BL, Chlebowski RT, Papoutsakis C, Shapiro A, Lubin MP, Thomson CA, Grosvenor MB, Copeland T, Falk E, Day K, Blackburn GL.

J Am Diet Assoc. 2009 Apr;109(4):688-96. doi: 10.1016/j.jada.2008.12.016.

43.

Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity.

Bai R, Edler MC, Bonate PL, Copeland TD, Pettit GR, Ludueña RF, Hamel E.

Mol Pharmacol. 2009 Jan;75(1):218-26. doi: 10.1124/mol.108.051110. Epub 2008 Oct 16.

44.

Rectal tacrolimus in the treatment of resistant ulcerative proctitis.

Lawrance IC, Copeland TS.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1214-20. doi: 10.1111/j.1365-2036.2008.03841.x. Epub 2008 Aug 30.

45.

Learning from error: identifying contributory causes of medication errors in an Australian hospital.

Nichols P, Copeland TS, Craib IA, Hopkins P, Bruce DG.

Med J Aust. 2008 Mar 3;188(5):276-9.

PMID:
18312190
46.

IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase.

Hodge DR, Cho E, Copeland TD, Guszczynski T, Yang E, Seth AK, Farrar WL.

Cancer Genomics Proteomics. 2007 Nov-Dec;4(6):387-98.

47.

Erythroid urea transporter deficiency due to novel JKnull alleles.

Wester ES, Johnson ST, Copeland T, Malde R, Lee E, Storry JR, Olsson ML.

Transfusion. 2008 Feb;48(2):365-72. Epub 2007 Nov 19.

PMID:
18028269
48.

PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.

Cho YW, Hong T, Hong S, Guo H, Yu H, Kim D, Guszczynski T, Dressler GR, Copeland TD, Kalkum M, Ge K.

J Biol Chem. 2007 Jul 13;282(28):20395-406. Epub 2007 May 11.

49.

CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.

Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK.

Curr Biol. 2007 Jan 23;17(2):179-84. Epub 2006 Dec 14.

50.

Polo-like kinase 1-mediated phosphorylation of the GTP-binding protein Ran is important for bipolar spindle formation.

Feng Y, Yuan JH, Maloid SC, Fisher R, Copeland TD, Longo DL, Conrads TP, Veenstra TD, Ferris A, Hughes S, Dimitrov DS, Ferris DK.

Biochem Biophys Res Commun. 2006 Oct 13;349(1):144-52. Epub 2006 Aug 14.

PMID:
16930555

Supplemental Content

Loading ...
Support Center